Comments Regarding Addition of Maximum Daily Exposure Information and Removing Dosage Information from the Inactive Ingredient Database

Docket Number:

FDA-2022-N-0236

CHPA appreciates the opportunity to provide feedback on the notice requesting comments on the Inactive Ingredient Database (IID). Responses to each of the questions listed by FDA in the March 22, 2022 notice are provided.

Download Document

Issues:

OTC Medicines

Other Issues

Comments Regarding Addition of Maximum Daily Exposure Information and Removing Dosage Information from the Inactive Ingredient Database

Related Posts